Journal of Clinical Endocrinology & Metabolism, Vol 56, 108-112, Copyright © 1983 by Endocrine Society

ARTICLES

Routine heparin therapy inhibits adrenal aldosterone production

R O'Kelly, F Magee and TJ McKenna

While heparin-induced aldosterone deficiency has been sporadically reported, it is not known whether heparin always inhibits aldosterone production to a variable extent or if this is an idiosyncratic effect, nor is the mechanism underlying the phenomenon known. We have examined plasma aldosterone, PRA, and aldosterone to renin activity ratios in 20 patients before, during and after treatment with heparin. Aldosterone cell during heparin treatment from 73.5 +/- 20.5 to 36.8 +/- 11.2 pg/ml (P less than 0.05) and rose after its withdrawal to 94.8 +/- 37.1 p/ml (P less than 0.05). PRA rose with heparin treatment from 2.8 +/- 1.0 to 6.1 +/- 1.6 ng/ml . h (P less than 0.05) and fell to 2.4 +/- 0.5 ng/ml . h (P less than 0.05) when the drug was withdrawn. Aldosterone to renin activity ratios, which are indices of aldosterone responsiveness to angiotensin, fell from 59.5 +/- 1.7 to 25 +/- 14.9 (P less than 0.01) with heparin treatment and rose after withdrawal of the drug to 58.5 +/- 24.9 (P less than 0.01). There was a significant small fall in serum sodium levels with the introduction of heparin, but none of the patients developed clinical mineralocorticoid deficiency. Although heparin consistently perturbs aldosterone production in the glomerulosa cell, this effect is not clinically significant when normal adjustments can be made in the generation of angiotensin. However, where limitations in the renin-angiotensin-aldosterone axis exist, e.g. in diabetes mellitus, mineralocorticoid insufficiency may be precipitated by heparin.

This article has been cited by other articles:

				F. Lanfranco, L. Gianotti, A. Picu, R. Giordano, G. A. Daga, V. Mondelli, G. Malfi, S. Fassino, E. Ghigo, and E. Arvat Effects of free fatty acids on ACTH and cortisol secretion in anorexia nervosa. Eur. J. Endocrinol., May 1, 2006; 154(5): 731 - 738. [Abstract] [Full Text] [PDF]

				F. Lanfranco, R. Giordano, M. Pellegrino, L. Gianotti, J. Ramunni, A. Picu, M. Baldi, E. Ghigo, and E. Arvat Free Fatty Acids Exert an Inhibitory Effect on Adrenocorticotropin and Cortisol Secretion in Humans J. Clin. Endocrinol. Metab., March 1, 2004; 89(3): 1385 - 1390. [Abstract] [Full Text] [PDF]

				N E. Norman, A. M Sneed, C. Brown, C. A Ellis, G. Minard, and R. O Brown Heparin-Induced Hyponatremia Ann. Pharmacother., March 1, 2004; 38(3): 404 - 407. [Abstract] [Full Text] [PDF]

				G. Miltiadous, D. P. Mikhailidis, and M. Elisaf Acid-Base and Electrolyte Abnormalities Observed in Patients Receiving Cardiovascular Drugs Journal of Cardiovascular Pharmacology and Therapeutics, December 1, 2003; 8(4): 267 - 276. [Abstract] [PDF]

				K. M. Kayes-Wandover, R. E. L. Schindler, H. C. Taylor, and P. C. White Type 1 Aldosterone Synthase Deficiency Presenting in a Middle-Aged Man J. Clin. Endocrinol. Metab., March 1, 2001; 86(3): 1008 - 1012. [Abstract] [Full Text]

				M. Camici and L. Evangelisti Heparin and Prostacyclin Angiology, April 1, 1989; 40(4): 294 - 299. [Abstract] [PDF]

				A. I. Knowlton Adrenal Insufficiency in the Intensive Care Setting J Intensive Care Med, January 1, 1989; 4(1): 35 - 45. [Abstract] [PDF]

				M. E. Williams and R. M. Rosa Hyperkalemia: Disorders of Internal and External Potassium Balance J Intensive Care Med, January 1, 1988; 3(1): 52 - 64. [Abstract] [PDF]